Related Experiment Video

Updated: Jul 14, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Soluble CD40 ligand and atrial fibrillation: relationship to platelet activation, and endothelial damage/dysfunction

A D Blann, A Choudhury, B Freestone

    International Journal of Cardiology
    |June 9, 2007
    PubMed

    Insights

    Soluble CD40L (sCD40L) levels are marginally increased in atrial fibrillation (AF) patients. The exact source of elevated sCD40L in AF remains unclear, as it did not correlate with platelet or endothelial markers.

    Area of Science:

    • Cardiovascular Medicine
    • Immunology
    • Biochemistry

    Background:

    • Elevated plasma soluble CD40L (sCD40L) is linked to cardiovascular diseases and poor prognosis.
    • The source of sCD40L in cardiovascular conditions, particularly atrial fibrillation (AF), is not fully understood.
    • This study investigates sCD40L levels in non-rheumatic AF and explores its potential origin.

    Discussion:

    • Plasma sCD40L levels were marginally higher in AF patients compared to controls.
    • While von Willebrand factor (vWf) and soluble P-selectin were elevated in AF, soluble E-selectin was not.
    • No significant correlations were found between sCD40L and the measured platelet or endothelial markers.

    Key Insights:

    • Soluble CD40L (sCD40L) shows a marginal increase in atrial fibrillation (AF).
    • The study did not find a significant correlation between sCD40L and platelet-derived soluble P-selectin or endothelial markers (vWf, soluble E-selectin).
    • These findings suggest that neither platelets nor the endothelium alone are the primary source of elevated sCD40L in AF.

    Outlook:

    • Further research is needed to elucidate the precise stimulus and source of increased sCD40L in AF.
    • Investigating other potential cellular sources or inflammatory pathways involved in sCD40L production in AF is warranted.
    • Understanding the origin of sCD40L may reveal novel therapeutic targets for managing AF and its cardiovascular complications.

    More Related Videos

    Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice11:18

    Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

    Published on: April 2, 2013

    Related Concept Videos

    Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

    Anticoagulant Drugs: Low-Molecular-Weight Heparins

    Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
    Formation of the Platelet Plug01:22

    Formation of the Platelet Plug

    The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
    As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
    Clot Retraction and Fibrinolysis01:16

    Clot Retraction and Fibrinolysis

    After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

    Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
    Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
    Intracellular Signaling Affects Focal Adhesions01:17

    Intracellular Signaling Affects Focal Adhesions

    Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
    Some...
    Coronary Artery Disease II: Pathophysiology01:26

    Coronary Artery Disease II: Pathophysiology

    Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...